IP Library Granted Patent US 7,767,432
Granted Patent B2
US 7,767,432 · App. 11/669,268 · Granted Aug 3, 2010

Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone B

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,767,432
App. No.
11/669,268
Granted
Aug 3, 2010
Kind
B2
Abstract

The present invention relates to improved methods for the production, isolation and purification of epothilone B. These methods include, for example, a fermentation process for the production of epothilone B, isolation via adsorption onto a resin, and subsequent purification.

Claims (8)

1. A strain of Sorangium cellulosum deposited as ATCC No. PTA-3880 or a strain of Sorangium cellulosum deposited as ATCC No. PTA-3881.

2. The strain of claim 1 deposited as ATCC No. PTA-3880.

3. The strain of claim 1 deposited as ATCC No. PTA-3881.

4. The strain of claim 1 , wherein said strain is capable of producing epothilone B in a recoverable amount upon fermentation in a nutrient medium.

5. The strain of claim 4 , wherein said strain is capable of improving the production ratio of epothilone B to epothilone A.

6. The strain of claim 5 , wherein said ratio of epothilone B to epothilone A ratio is at least 1.

7. The strain of claim 6 , wherein said ratio of epothilone B to epothilone A ratio is at least 1.5.

8. The strain of claim 7 , wherein said ratio of epothilone B to epothilone A ratio is in the range of 1.5 to 4.0.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2015
From: BRISTOL-MYERS SQUIBB COMPANY
To: R-PHARM US OPERATING LLC
Reel/Frame 036585/0956 →